Numeta G13e

Valine, the active ingredient in Numeta G13e, is a parenteral nutrition supplement presented as a solution for intravenous use. It supports patients who require comprehensive amino acid nutrition, particularly in critical care and postoperative settings. GNH USA supplies Numeta G13e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Numeta G13e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Numeta G13e is used in clinical nutrition to provide essential amino acids for patients with increased metabolic needs.

- Critical care: helps maintain nitrogen balance and supports protein synthesis in intensive care patients. - Post‑operative recovery: aids tissue repair and wound healing after major surgery. - Long‑term parenteral nutrition: supplies a balanced amino acid profile for patients dependent on intravenous nutrition.

Numeta G13e may be associated with infusion‑related reactions and metabolic disturbances.

Common Side Effects: - Hyperglycaemia: elevated blood glucose levels during infusion. - Electrolyte imbalance: changes in serum potassium or phosphate. - Mild fever: low‑grade temperature rise during administration. - Local irritation: redness or discomfort at the infusion site.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Metabolic acidosis: significant drop in blood pH due to amino acid metabolism. - Hepatic dysfunction: abnormal liver enzyme elevations. - Sepsis: infection risk linked to central venous catheter use.

When using Numeta G13e, clinicians should assess patient-specific factors and monitor relevant parameters.

- Renal function: adjust infusion rate in patients with impaired kidney function. - Hepatic function: monitor liver enzymes in patients with liver disease. - Blood glucose: regularly check glucose levels, especially in diabetic patients. - Electrolytes: track serum electrolytes to detect imbalances early. - Compatibility: verify compatibility with other intravenous solutions before co‑administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Numeta G13e may interact with other intravenous therapies and medications that affect metabolic balance.

Major Interactions (Avoid): - High‑dose insulin: may exacerbate hypoglycaemia when combined with amino‑acid infusion. - Potassium‑rich solutions: can cause severe hyperkalaemia when mixed with Numeta G13e.

Moderate Interactions (Monitor Closely): - Diuretics: may increase risk of electrolyte disturbances. - Corticinal corticosteroids: can alter protein metabolism. - Anticoagulants antico  - Antifungal  -